AIA Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.06M | Buy |
17,257
+1,164
| +7% | +$611K | 0.2% | 65 |
|
|
2025
Q1 | $10.2M | Buy |
16,093
+2,493
| +18% | +$1.58M | 0.25% | 56 |
|
|
2024
Q4 | $9.69M | Buy |
13,600
+2,959
| +28% | +$2.11M | 0.23% | 53 |
|
|
2024
Q3 | $11.2M | Buy |
10,641
+621
| +6% | +$653K | 0.29% | 47 |
|
|
2024
Q2 | $10.5M | Buy |
10,020
+3,132
| +45% | +$3.29M | 0.31% | 43 |
|
|
2024
Q1 | $6.63M | Buy |
6,888
+2,166
| +46% | +$2.08M | 0.22% | 50 |
|
|
2023
Q4 | $4.15M | Buy |
4,722
+565
| +14% | +$496K | 0.17% | 66 |
|
|
2023
Q3 | $3.42M | Sell |
4,157
-554
| -12% | -$456K | 0.17% | 66 |
|
|
2023
Q2 | $3.39M | Buy |
4,711
+1,077
| +30% | +$774K | 0.16% | 71 |
|
|
2023
Q1 | $2.99M | Sell |
3,634
-2,324
| -39% | -$1.91M | 0.16% | 57 |
|
|
2022
Q4 | $4.3M | Sell |
5,958
-722
| -11% | -$521K | 0.26% | 38 |
|
|
2022
Q3 | $4.6M | Buy |
6,680
+1,601
| +32% | +$1.1M | 0.3% | 39 |
|
|
2022
Q2 | $3M | Buy |
5,079
+1,845
| +57% | +$1.09M | 0.16% | 58 |
|
|
2022
Q1 | $2.26M | Buy |
3,234
+1,439
| +80% | +$1.01M | 0.1% | 94 |
|
|
2021
Q4 | $1.13M | Buy |
1,795
+696
| +63% | +$440K | 0.05% | 132 |
|
|
2021
Q3 | $665K | Buy |
1,099
+385
| +54% | +$233K | 0.04% | 157 |
|
|
2021
Q2 | $418K | Sell |
714
-804
| -53% | -$471K | 0.03% | 152 |
|
|
2021
Q1 | $718K | Buy |
1,518
+295
| +24% | +$140K | 0.1% | 99 |
|
|
2020
Q4 | $601K | Buy |
+1,223
| New | +$601K | 0.07% | 108 |
|